• WARRIOR Trial: Outcomes to Reduce Events in Non-Obstructive Coronary Artery Disease

  • May 6 2025
  • Duración: 11 m
  • Podcast

WARRIOR Trial: Outcomes to Reduce Events in Non-Obstructive Coronary Artery Disease

  • Resumen

  • Funded by the Congressionally Directed Medical Research Programs (CDMRP) of the Department of Defense, the WARRIOR (Women's IschemiA TRial to Reduce events In non-ObstRuctive CAD) Trial addresses the urgent need for evidence-based care in a growing population of patients—particularly women—experiencing ischemia without obstructive coronary artery disease (INOCA).

    This clinical strategy trial compares optimal medical therapy with usual care in women with angina but no significant coronary blockages. In this episode, Drs. Nanette Kass Wenger and Noel Bairey Merz discuss the trial’s design, enrollment progress, follow-up strategies, and the primary and secondary outcomes that could reshape cardiovascular care for women.

    Subscribe on Apple Podcasts || Subscribe to ACCEL

    Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre WARRIOR Trial: Outcomes to Reduce Events in Non-Obstructive Coronary Artery Disease

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.